Louis Vermeulen

Amsterdam Neuroscience — Netherlands

Medicine · Health Sciences

57h-index22.4kcitations307works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(97), Cancer Cells and Metastasis(94), Genetic factors in colorectal cancer(92), Cancer Genomics and Diagnostics(53), Pancreatic and Hepatic Oncology Research(28)

Publications307 total

Abstract A018: Investigating the role of cancer-associated fibroblasts in colorectal cancer peritoneal metastasis
Cancer Research·2025
Malignancies of the small intestine: incidence and trends in a nationwide registry
Cancer Epidemiology·2025Open Access
Acute Pericentral Liver Injury Induces a Novel Transient Hepatocyte Population
2025Open Access
Molecular Classification of Resected Primary Duodenal Adenocarcinoma
Genes Chromosomes and Cancer·2025Open Access
An old spice with new tricks: Curcumin targets adenoma and colorectal cancer stem-like cells associated with poor survival outcomes
Cancer Letters·2025· 4 citedOpen Access
Supplementary Figure 2 from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
Supplementary Table 4 from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
Supplementary Table 1 from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
Supplementary Figure 5 from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
Supplementary Figure 4 from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
Supplementary Figure 3 from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
Supplementary Table 2 from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
Data from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
Supplementary Table 5 from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
Supplementary Methods 1 from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
Supplementary Figure 1 from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
Supplementary Table 3 from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
Supplementary Table 6 from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
Supplementary Figure 6 from Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
2025Open Access
High human papillomavirus viral load and local immune dysregulation are associated with poor clinical outcomes in patients with cervical cancer
International Journal of Gynecological Cancer·2025· 1 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Jan Paul Medema(29), Felipe de Sousa e Melo(13), Xin Wang(9), Evelyn Fessler(9), Giorgio Stassi(7), Jan Köster(7), Maartje van der Heijden(6), Jurriaan B. Tuynman(6), Kristel Kemper(6), Maarten F. Bijlsma(6), Joan H. de Jong(5), Hans M. Rodermond(5), Dick J. Richel(5), Evelien Dekker(5), Douglas J. Winton(5), Cornelis J.A. Punt(5), Sabine Tejpar(4), Martin R. Sprick(4), Edward Morrissey(4), Janneke F. Linnekamp(4)